Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases.
- DOI
- 10.1016/s2665-9913(26)00248-1
- Published
- 2026 Oct
- Container
- The Lancet. Rheumatology
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/s2665-9913-26-00248-1,
title = {Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases.},
author = {Plein S and Youngstein T and Weber B and Buch MH},
year = {2026},
journal = {The Lancet. Rheumatology},
doi = {10.1016/s2665-9913(26)00248-1},
url = {https://doi.org/10.1016/s2665-9913(26)00248-1}
}RIS
TY - JOUR TI - Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases. AU - Plein S AU - Youngstein T AU - Weber B AU - Buch MH PY - 2026 JO - The Lancet. Rheumatology DO - 10.1016/s2665-9913(26)00248-1 UR - https://doi.org/10.1016/s2665-9913(26)00248-1 ER -
APA
S, P., T, Y., B, W., & MH, B. (2026). Relevance of the 2025 ESC guidelines for the diagnosis and management of myocarditis and pericarditis for systemic autoimmune rheumatic diseases.. The Lancet. Rheumatology. https://doi.org/10.1016/s2665-9913(26)00248-1
Source records
- pubmed · retrieved 2026-09-26T03:58:23.103Z